Design, synthesis and biological evaluation of bisindole derivatives as anticancer agents against Tousled-like kinases
- 1 January 2022
- journal article
- research article
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 227, 113904
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Science and Technology, Taiwan (MOST109-2311-B-038-001)
- Ministry of Science and Technology, Taiwan (108-2311-B-038-001)
- Academia Sinica
- Ministère de l'Éducation, Gouvernement de l'Ontario
- Det Sundhedsvidenskabelige Fakultet, Københavns Universitet
This publication has 31 references indexed in Scilit:
- A broad activity screen in support of a chemogenomic map for kinase signalling research and drug discoveryBiochemical Journal, 2013
- Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivityNature Biotechnology, 2011
- Tousled homolog, TLK1, binds and phosphorylates Rad9; TLK1 acts as a molecular chaperone in DNA repairDNA Repair, 2009
- Replication licensing and cancer — a fatal entanglement?Nature Reviews Cancer, 2008
- Living on a break: cellular senescence as a DNA-damage responseNature Reviews Cancer, 2008
- An Oncogene-Induced DNA Damage Model for Cancer DevelopmentScience, 2008
- Tousled-like kinase in a microbial eukaryote regulates spindle assembly and S-phase progression by interacting with Aurora kinase and chromatin assembly factorsJournal of Cell Science, 2007
- The C. elegans Tousled-like Kinase Contributes to Chromosome Segregation as a Substrate and Regulator of the Aurora B KinaseCurrent Biology, 2005
- Tousled-like kinase functions with the chromatin assembly pathway regulating nuclear divisionsGenes & Development, 2003
- Suppression of Tousled-like kinase activity after DNA damage or replication block requires ATM, NBS1 and Chk1Oncogene, 2003